Your session is about to expire
← Back to Search
Bortezomib for Multiple Myeloma
Study Summary
This trial is testing a possible new treatment for multiple myeloma that combines three drugs.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many venues can participants access this research experiment?
"A total of 8 medical centres are enrolling participants in this trial. Notable sites include Hematology Oncology of Northern New jersey, Eastern Maine Medical Center and Beth Israel Deaconess Medical Center, alongside 5 other locations."
To what extent have there been prior experiments utilizing Bortezomib?
"Currently, there are 168 phase 3 trials actively exploring the potential of Bortezomib. Of these studies, 732 remain active while Joliet Illinois alone hosts several clinical trials on this medication. Moreover, 26078 medical centres around the world have conducted research concerning Bortezomib's efficacy."
In which circumstances is Bortezomib typically prescribed?
"Bortezomib is mostly employed to treat ophthalmia, sympathetic. Additionally, it can be used for a variety of other illnesses, such as macular edema, branch retinal vein occlusion and two or more prior systemic chemotherapy regimens."
Has the FDA accepted Bortezomib for clinical use?
"The level of safety associated with Bortezomib was estimated to be a 2 by our team at Power as it is currently in Phase 2 trials, suggesting that while there are some data points alluding to its safety, efficacy has yet to be proven."
Is this research endeavor currently accepting participants?
"This study is no longer actively recruiting participants. It was initially posted in December of 2015 and edited most recently on February 11th 2022. For those seeking alternative studies, 807 trials involving multiple myeloma are presently enrolling and 732 clinical experiments utilizing bortezomib have vacancies for volunteers."
What is the planned enrollment size for this research endeavor?
"At this moment, there are no open slots for participants in this trial. This medical study was first advertised on December 1st 2015 and most recently updated February 11th 2022. For those searching for other trials related to multiple myeloma or Bortezomib, 807 and 732 clinical trials are respectively recruiting patients across the globe."
Share this study with friends
Copy Link
Messenger